The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the safety and activity of formulated IL-12 plasmid administered intraperitoneally in combination with neoadjuvant chemotherapy in patients with newly diagnosed advanced-stage ovarian cancer.
 
Premal H. Thaker
Stock and Other Ownership Interests - Celsion
Consulting or Advisory Role - Abbvie/Stemcentrx; Abbvie/Stemcentrx; Celsion; Clovis Oncology; Iovance Biotherapeutics; Stryker; Tesaro; Unleash
Speakers' Bureau - Merck; Tesaro
Research Funding - Merck (Inst)
 
William Hampton Bradley
Consulting or Advisory Role - Celsion
 
Charles A. Leath
Honoraria - Mateon Therapeutics
Consulting or Advisory Role - Celsion; Unleash Immuno Oncolytics
 
Camille Catherine Gunderson
No Relationships to Disclose
 
Nicholas Borys
Employment - Celsion
Leadership - Celsion
Stock and Other Ownership Interests - Celsion
 
Lauren Musso
Employment - Celsion
Stock and Other Ownership Interests - Celsion
 
Khursheed Anwer
Employment - Celsion
Leadership - Celsion
Stock and Other Ownership Interests - Celsion
Patents, Royalties, Other Intellectual Property - Celsion
 
Ronald David Alvarez
Consulting or Advisory Role - Clovis Oncology; Pierian Biosciences; Unleash; Vaccitech